Balderton Capital and Exor Ventures have led a seed round to help finance clinical trials and expand manufacturing capabilities.
"At SAVA we are tackling preventable illness by building a new operating system for health monitoring. Our microsensor will revolutionise healthcare by making world-leading monitoring technology available to all. With this capital, we can accelerate our goal of creating a new paradigm for healthcare – preventative, personalised and painless."
The seed financing was co-led by UKI2S and Cambridge Enterprise Ventures to support the commercial deployment of photonic chip designs.
"The team has spent the past few years building and experimentally validating our design technology – it’s exciting to have the resources to begin deploying it to solve real industry problems."
The seed round was led by Hoxton Ventures with participation from Basis Set Ventures and Lightspeed Venture Partners.
"The Fundamental AI Research (FAIR) team is looking forward to collaborating with CuspAI in their use of AI, including our OpenDAC work, to accelerate the discovery of novel DAC sorbent materials. The world needs fast progress on affordable carbon capture, and we believe that CuspAI’s team is in an excellent position to apply AI-based materials discovery to this pressing problem."
The BBC backed the Bristol-based technology startup to develop immersive live experiences for younger audiences.
"The more that this technology moves on, the more we’re going to get closer to that live experience and I think that’s so special. This is a much more accessible way for people to hear live music and I’m all for that."